SCHEMBL24144502

SCHEMBL24144502

NCCc1cn(Cc2cccc(F)c2)c2cc(-c3ccncc3)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.47
▸ ICMT O60725 2/20 0.43
▸ MKNK1 Q9BUB5 1/20 0.42
▸ MKNK2 Q9HBH9 1/20 0.42
▸ TAAR1 Q96RJ0 2/20 0.42
▸ HTR6 P50406 1/20 0.41
▸ NR1D1 P20393 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ NTSR1 P30989 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP11B1 P15538 1/20 0.41
▸ CYP11B2 P19099 1/20 0.41
▸ CDC7 O00311 1/20 0.41
▸ ROCK2 O75116 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24143548 0.88 NFATC1 (0.50) CYP19A1HTR6NR1D1LMNAKDM4E
SCHEMBL24144070 0.88 HTR6 (0.54) CYP19A1ICMTHTR6NR1D1POLB
SCHEMBL24144386 0.87 LMNA (0.45) MKNK1MKNK2TAAR1HTR6NR1D1
SCHEMBL24144383 0.87 CYP19A1 (0.49) CYP19A1TAAR1HTR6NR1D1POLB
SCHEMBL24144290 0.87 HTR6 (0.41) CYP19A1HTR6NR1D1ROCK2GSK3B
SCHEMBL24144381 0.87 ICMT (0.50) ICMTMKNK1MKNK2TAAR1HTR6
SCHEMBL24143540 0.85 NR1D1 (0.42) HTR6NR1D1KDM4EMEN1HTT
SCHEMBL24143551 0.85 NR1D1 (0.41) CYP19A1MKNK1MKNK2HTR6NR1D1
SCHEMBL24143555 0.85 ROCK2 (0.46) TAAR1HTR6NR1D1KMT2ACYP3A4
SCHEMBL24143557 0.84 CYP19A1 (0.45) CYP19A1MKNK1MKNK2TAAR1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback